| AIDS 347: IL-6 Blockade in Treated HIV Infection (NCT02049437) | Case Western Reserve University | 2014-08-01 |
| the Pharmacokinetic Profiles of Losartan With DW1029M (NCT02212769) | Dong Wha Pharmaceutical Co. Ltd. | 2014-08-01 |
| Relative Bioavailability Study With Enalapril in Healthy Volunteers (NCT02252692) | Ethicare GmbH | 2014-08-01 |
| Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2 (NCT02043171) | Metabolic Technologies Inc. | 2014-08-01 |
| Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI (NCT01772810) | Neuralstem Inc. | 2014-08-01 |
| A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies (NCT02244112) | Amgen | 2014-08-01 |
| Comparison Between Land-based and Water-based Exercises for Knee Osteoarthritis: Randomized Controlled Trial (NCT02295605) | University of Nove de Julho | 2014-08-01 |
| Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus (NCT02201199) | Sanofi | 2014-08-01 |
| A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5 (NCT02181088) | University of Oxford | 2014-08-01 |
| Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot Study (NCT02457858) | University of Alberta | 2014-08-01 |
| Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis (NCT03391414) | Joseph Pilewski | 2014-08-01 |
| A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects (NCT02240160) | GW Pharmaceuticals Ltd | 2014-08-01 |
| A Study Of PF-06664178 In Patients With Advanced Solid Tumors (NCT02122146) | Pfizer | 2014-08-01 |
| Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects (NCT02178254) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-08-01 |
| Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease (NCT02216877) | Zealand University Hospital | 2014-08-01 |
| A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users (NCT02218021) | Alkermes, Inc. | 2014-08-01 |
| Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer (NCT02207504) | Dana-Farber Cancer Institute | 2014-08-01 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers (NCT02228707) | Biogen | 2014-08-01 |
| Bioavailability of Omega-3 Food Supplement in Healthy Subjects (NCT02376608) | Pronova BioPharma | 2014-08-01 |
| Study of the Electrocardiographic Effects of TA-8995 (NCT02241759) | Xention Ltd | 2014-08-01 |
| An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis (NCT02195440) | Komagome Hospital | 2014-08-01 |
| Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients (NCT02269566) | Gachon University Gil Medical Center | 2014-08-01 |
| Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial (NCT02219893) | Oslo University Hospital | 2014-08-01 |
| Icotinib Hydrochloride in Treating Patients With Advanced Cancers (NCT02033148) | Roswell Park Cancer Institute | 2014-08-01 |
| Omnitram Pharmacokinetic Study In Healthy Volunteers (NCT02205554) | Syntrix Biosystems, Inc. | 2014-08-01 |
| Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? (NCT02226484) | University of North Carolina, Chapel Hill | 2014-08-01 |
| A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma (NCT02210182) | Oncozyme Pharma Inc. | 2014-08-01 |
| Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation (NCT02137642) | Motus Therapeutics, Inc. | 2014-08-01 |
| Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers (NCT02210247) | Pacira Pharmaceuticals, Inc | 2014-08-01 |
| Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer (NCT02219711) | Mirati Therapeutics Inc. | 2014-08-01 |
| Clopidogrel Bioequivalence Study in Healthy Subjects (NCT02185534) | AstraZeneca | 2014-08-01 |
| Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris (NCT02411942) | Sun Pharmaceutical Industries, Inc. | 2014-08-01 |
| Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers (NCT02215941) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-08-01 |
| A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects (NCT02222324) | Eisai Inc. | 2014-08-01 |
| Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors (NCT02134067) | Taiho Oncology, Inc. | 2014-08-01 |
| TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM (NCT02202993) | Cavion, Inc. | 2014-08-01 |
| A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects (NCT02208284) | Pfizer | 2014-08-01 |
| A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules (NCT02531204) | Astellas Pharma Inc | 2014-08-01 |
| EIMD Mechanisms Causing Force Loss (NCT02125643) | University of Oklahoma | 2014-08-01 |
| Study of IRX4204 for Treatment of Early Parkinson's Disease (NCT02438215) | Io Therapeutics | 2014-08-01 |
| Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors (NCT02235688) | ImmunityBio, Inc. | 2014-08-01 |
| Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2 (NCT02178059) | AstraZeneca | 2014-08-01 |
| Study to Measure Relaxation From Different Types of Focused Breathing Exercises (NCT02226744) | Vanderbilt University Medical Center | 2014-08-01 |
| Improving Medication-taking After Liver Transplant (NCT01960322) | Icahn School of Medicine at Mount Sinai | 2014-08-01 |
| Study to Determine How BCX4161 is Metabolized and Eliminated by the Body (NCT02218294) | BioCryst Pharmaceuticals | 2014-08-01 |
| External Beam Radiotherapy for Muscle Invasive Bladder Cancer (NCT02748200) | University Hospital, Ghent | 2014-08-01 |
| A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer (NCT02081495) | Janssen Research & Development, LLC | 2014-08-01 |
| Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation. (NCT02279147) | Wanqing Gu | 2014-08-01 |
| Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167 (NCT02260830) | H. Lundbeck A/S | 2014-08-01 |
| Mild, Moderate and Severe Renal Impairment Study (NCT02219516) | Ardea Biosciences, Inc. | 2014-08-01 |
| (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer (NCT02132403) | University of Illinois at Chicago | 2014-08-01 |
| Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies (NCT01880996) | Sheba Medical Center | 2014-08-01 |
| TNS for Treating Nicotine Craving (NCT02178852) | Santa Casa Medical School | 2014-08-01 |
| A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects (NCT02061878) | ReXceptor, Inc. | 2014-08-01 |
| Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults (NCT02174978) | U.S. Army Medical Research and Development Command | 2014-08-01 |
| L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer (NCT02215083) | Eastern Regional Medical Center | 2014-08-01 |
| Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation (NCT02337595) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2014-08-01 |
| A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects (NCT02211469) | Bristol-Myers Squibb | 2014-08-01 |
| Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody (NCT02216409) | Gilead Sciences | 2014-08-01 |
| Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease (NCT01771731) | University of California, San Francisco | 2014-08-01 |
| ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin (NCT02435927) | National Cancer Centre, Singapore | 2014-08-01 |
| The Role of Vitamin D in Female Reproductive Tract Immunity (NCT02186535) | CONRAD | 2014-08-01 |
| Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects (NCT02207595) | UCB Celltech | 2014-08-01 |
| Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease (NCT02216630) | Kimera Society Inc | 2014-08-01 |
| The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study (NCT02176044) | King's College London | 2014-08-01 |
| Pectin Start Early Enteral Nutritional Support in Critically Ill Patients (NCT02379624) | Xingwei Xu | 2014-08-01 |
| The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) (NCT02116712) | Tony Eissa | 2014-08-01 |
| A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers (NCT02214433) | Debiopharm International SA | 2014-08-01 |
| Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662 (NCT02194244) | Hoffmann-La Roche | 2014-08-01 |
| Effects of Moringa Oleifera on hsCRP and Hgba1c Level of Patients in Ospital ng Maynila Medical Center Diabetic Clinic (NCT02308683) | Ospital ng Maynila Medical Center | 2014-08-01 |
| A Study of LY2409021 in Healthy Participants (NCT02217618) | Eli Lilly and Company | 2014-08-01 |
| A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids) (NCT02209766) | AstraZeneca | 2014-08-01 |
| Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT02201329) | Boehringer Ingelheim | 2014-08-01 |
| Absolute Bioavailability Of Bosutinib (NCT02192294) | Pfizer | 2014-08-01 |
| Dendritic Killer Cell-based Immunotherapy for Solid Tumors (NCT02882659) | FullHope Biomedical Co., Ltd. | 2014-08-01 |
| A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers (NCT01803399) | GlaxoSmithKline | 2014-08-01 |
| A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer (NCT02236000) | NSABP Foundation Inc | 2014-08-01 |
| Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects (NCT02068235) | Actelion | 2014-08-01 |
| To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI (NCT02145897) | Kasiak Research Pvt. Ltd. | 2014-08-01 |
| Multiple Dose BE Study With Nevirapine 400mg PR Tablets (NCT02202005) | Ratiopharm GmbH | 2014-08-01 |
| Pharmacokinetics and Safety Study of LBAL in Healthy Subjects (NCT02206867) | LG Life Sciences | 2014-08-01 |
| Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults (NCT02165267) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-08-01 |
| Two-way Interaction Between Alisporivir and EDP239 (NCT02173574) | Enanta Pharmaceuticals, Inc | 2014-08-01 |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer (NCT01958372) | Barbara Ann Karmanos Cancer Institute | 2014-08-01 |
| Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants (NCT02220218) | Janssen Research & Development, LLC | 2014-08-01 |
| Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline (NCT02256033) | Kyowa Kirin Co., Ltd. | 2014-08-01 |
| Prevention of Drug Use in Adolescence: Intervening in Parenting Styles (NCT02386280) | Federal University of Health Science of Porto Alegre | 2014-08-01 |
| Treatment -Resistant Neovascular Age-Related Macular Degeneration (NCT02332941) | Washington University School of Medicine | 2014-08-01 |
| Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects (NCT02159131) | ViiV Healthcare | 2014-08-01 |
| An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal (NCT02169804) | Repros Therapeutics Inc. | 2014-08-01 |
| Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome (NCT02212561) | St. Jude Children's Research Hospital | 2014-08-01 |
| PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine (NCT02239172) | Fraunhofer, Center for Molecular Biotechnology | 2014-08-01 |
| Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788 (NCT02255968) | Enanta Pharmaceuticals, Inc | 2014-08-01 |
| PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study (NCT02367937) | Pronova BioPharma | 2014-08-01 |
| Pharmacokinetic Study of MTC896 Gel in Subjects With Acne (NCT02293018) | Mimetica Pty Limited | 2014-08-01 |
| Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer (NCT02077881) | NewLink Genetics Corporation | 2014-08-01 |
| Safety, Tolerability and Efficacy Study of PP1420 in HV (NCT02221765) | Imperial College London | 2014-08-01 |
| Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects (NCT02156466) | Merck KGaA, Darmstadt, Germany | 2014-08-01 |
| A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck) (NCT02480049) | Genuine Research Center, Egypt | 2014-08-01 |
| Food Effect Study of AG-221 in Healthy Male Subjects (NCT02218346) | Agios Pharmaceuticals, Inc. | 2014-08-01 |